AVN-944
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


AVN-944
Description :
AVN-944 (VX-944) is an orally active, potent, selective, noncompetitive and specific inhibitor of IMPDH (inosine monophosphate dehydrogenase) . AVN-944 is an essential rate-limiting enzyme in de novo guanine nucleotide synthesis. AVN-944 is also an inhibitor of arenavirus RNA synthesis, and blocks arenavirus infection. AVN-944 has broad anti-cancer activities, and can be used for multiple myeloma (MM) and acute myeloid leukemia (AML) research[1][2][3].Product Name Alternative :
VX-944UNSPSC :
12352005Hazard Statement :
H302, H315, H319, H335Target :
Apoptosis; Arenavirus; Bcl-2 Family; Caspase; DNA/RNA SynthesisType :
Reference compoundRelated Pathways :
Anti-infection; Apoptosis; Cell Cycle/DNA DamageApplications :
Cancer-programmed cell deathField of Research :
Cancer; InfectionAssay Protocol :
https://www.medchemexpress.com/AVN-944.htmlPurity :
99.89Solubility :
DMSO : 100 mg/mL (ultrasonic)Smiles :
O=C(O[C@@H](CC#N)CC)N[C@H](C1=CC=CC(NC(NC2=CC=C(C3=CN=CO3)C(OC)=C2)=O)=C1)CMolecular Formula :
C25H27N5O5Molecular Weight :
477.51Precautions :
H302, H315, H319, H335References & Citations :
[1]Zimmermann AG, et al. Inosine-5'-monophosphate dehydrogenase: regulation of expression and role in cellular proliferation and T lymphocyte activation. Prog Nucleic Acid Res Mol Biol. 1998;61:181-209.|[2]Huang M, et al. Guanine nucleotide depletion inhibits pre-ribosomal RNA synthesis and causes nucleolar disruption. Leuk Res. 2008 Jan;32 (1) :131-41.|[3]Floryk D, et al. Antiproliferative effects of AVN944, a novel inosine 5-monophosphate dehydrogenase inhibitor, in prostate cancer cells. Int J Cancer. 2008 Nov 15;123 (10) :2294-302.Shipping Conditions :
Room TemperatureStorage Conditions :
-20°C, 3 years; 4°C, 2 years (Powder)Scientific Category :
Reference compound1Clinical Information :
Phase 2Isoform :
Bak; Bax; Caspase 3; Caspase 8; Caspase 9CAS Number :
[297730-17-7]

